From UBC’s novel drug delivery system that enabled Pfizer/BioNTech SE and Moderna to create mRNA vaccines, to being the first university in the world to publish structural images of the Alpha variant spike protein at near-atomic resolution to assess antibody treatments, UVX is very honoured to be recognized amongst very important technologies spinning out of the UBC ecosystem.
UVX is pleased to be one of 25 companies to receive a total of $2.5M in funding from the Government of Canada via Sustainable Development Technology Canada (SDTC). SDTC helps promising startups accelerate the deployment of globally competitive clean technology solutions. We are so grateful to the Government of Canada for their continued support as UVX becomes the first Canadian manufacturer to commercialize Far-UVC technology for Canada and the world!
UVX helps businesses reduce infection transmission risk through innovative light-based technology. The team has developed the world’s first intelligent ceiling device that continuously kills pathogens within seconds. Their technology disinfects both air and surfaces, even when people are present in the room.
UVX co-founders Saimir and Kunal helped install Zener devices at Louis Brier Home and Hospital, one of Canada's largest senior care facilities with 215 beds.
Canadian coast-to-coast, listeners learned about UVX on The Shift, a Global News radio segment and Canada’s most listened to night time radio. When the radio team reached out for their segment on UV technologies, we didn’t think the unpaid feature would result in overwhelming inbound interest, from cannabis growers to dental clinics to a hospital. Thank you for the feature, Handy Andy and Global News. Have a listen!
The TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator organized a Canada-wide healthcare challenge. UVX was selected as Top 20 in February 2022, and then moved on to Top 10, and then ultimately to Top 5. A cohort of 35 investors then conducted due diligence on the Top 5 companies over 6-weeks, ultimately determining UVX to be Canada's most impactful and investable healthcare startup.
New Ventures BC is British Columbia’s largest (and most selective) industry-agnostic startup competition, with a panel of 95 judges from various industries. Over the coming months, UVX and a bunch of other great startups will be competing to win $250,000 in cash and prizes.
After months of evaluating amazing healthcare ventures, the TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator select UVX as a Top 20 healthcare company Canada-wide.
UVX co-founders Saimir and Kunal demonstrated Zener, UVX's first product, at University of British Columbia's e@UBC Venture Showcase. In the category that UVX was presenting, UVX placed 2nd for People's Choice Award.
UVX is excited to announce that the Division of Infectious Diseases, within the Faculty of Medicine at the University of British Columbia (UBC), has commenced testing of UVX’s core technology: filtered 222nm Far-UVC light produced by UVX’s flagship Zener device. The tests will be conducted at the Jack Bell Research Centre.
The negative socio-economic effects of infectious diseases are undeniable. Yet traditional chemical disinfectants and UV solutions fail to effectively and efficiently mitigate these issues. Recognizing the shortcomings of traditional methods, UVX makes disinfection effortless, affordable, effective, sustainable, and safe for everyone.
Engineer Kunal Sethi is secretive about what, exactly, his revolutionary germ-zapper will look like. But it will be small, he says: a programmable, ceiling-mounted device roughly the size of a Wi-Fi router that quietly bathes entire rooms in ultraviolet light — potentially saving tens of thousands of lives each year.
Discover the Canadian healthtech start-ups to watch in 2021. MEDTEQ+, through its AIM coaching program, has selected about twenty promising companies in health technologies.